Jazz Pharmaceuticals vs Solventum
Jazz Pharmaceuticals (JAZZ), health care, and Solventum (SOLV), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Jazz Pharmaceuticals is worth $15.5B on the stock market and Solventum $14.6B: Jazz Pharmaceuticals is valued at 6% more. Jazz Pharmaceuticals trades at 71.2 times earnings and Solventum at 96.7; operating margins in their latest fiscal years were -10.1% and 26.2%. Over the past year Jazz Pharmaceuticals's share price has moved +32.8% and Solventum's +15.3%.
Key facts
- Jazz Pharmaceuticals market value
- $15.5B
- Solventum market value
- $14.6B
- Jazz Pharmaceuticals P/E
- 71.2
- Solventum P/E
- 96.7
- Jazz Pharmaceuticals revenue
- $4.3BFY to 2025-12-31
- Solventum revenue
- $8.3BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Jazz Pharmaceuticals | Solventum |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $15.5Bhigher | $14.6Blower |
| Revenue | $4.3Blower | $8.3Bhigher |
| Earnings | -$356.1Mlower | $1.6Bhigher |
| Employees | 2,890lower | 20,584higher |
| Total assets | $11.7Blower | $14.3Bhigher |
| Valuation | ||
| P/E | 71.2lower | 96.7higher |
| P/S | 3.6higher | 1.8lower |
| P/B | — | 3.0 |
| Dividend yield | — | 0.00% |
| Profitability | ||
| Operating margin | -10.1%lower | 26.2%higher |
| Balance sheet | ||
| Net assets | $4.3Blower | $5Bhigher |
| Total liabilities | $7.3Blower | $9.2Bhigher |
| Total debt | $5.4Bhigher | $5Blower |
| Cash on hand | $1.4Bhigher | $878Mlower |
| Price change | ||
| Today | +0.39%higher | -2.92%lower |
| 1 year | +32.8%higher | +15.3%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Jazz Pharmaceuticals only (5)
Solventum only (6)
- Nelson Peltz15.0%
- Christopher Davis2.4%
- Diamond Hill team1.5%
- Joel Greenblatt0.1%
- Richard Pzena0.1%
- Mairs & Power team0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns JAZZ · Who owns SOLV
More on Jazz Pharmaceuticals
Further comparisons
Jazz Pharmaceuticals against its closest peers
Solventum against its closest peers
Learn
Questions and answers
Which is bigger, Jazz Pharmaceuticals or Solventum?
By market value, Jazz Pharmaceuticals is the larger: $15.5B against $14.6B for Solventum. By revenue in its latest fiscal year, Solventum is the larger: $8.3B against $4.3B for Jazz Pharmaceuticals.
Which has the higher P/E ratio?
Solventum: 96.7, against 71.2 for Jazz Pharmaceuticals. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Solventum: 26.2%, against -10.1% for Jazz Pharmaceuticals. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Jazz Pharmaceuticals: $5.4B, against $5B for Solventum. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Jazz Pharmaceuticals and Solventum?
None of the tracked superinvestors holds both in their latest 13F filing. 5 hold Jazz Pharmaceuticals and 6 hold Solventum.
Cite this page
Funkfolio, “Jazz Pharmaceuticals vs Solventum”, data as of 17 November 2026. https://funkfolio.com/compare/jazz-vs-solv
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.